From MDS/AML to iPSC and back again.
Level V
Where this comes from
- Record sourced from PubMed, PMID 28275157.
- Also identified by DOI 10.1126/scitranslmed.aam9861 and PMC identifier 5494265.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
iPSC lines derived from MDS and AML patient samples can map clonal evolution, disease progression and regression, and identify disease stage-specific medication effects.
Medical subject headings
- Induced Pluripotent Stem Cells
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes